Loading...

PerCP/Cyanine5.5 anti-mouse CD45 Antibody PerCP/Cyanine5.5 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
103132 100 µg NOK1824
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103131 25 µg NOK718
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  2. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  3. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  4. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  5. Zaman R, et al. 2021. Immunity. :. PubMed
  6. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  7. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  8. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  9. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  10. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  11. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  12. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  13. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  14. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  15. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  16. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  17. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  18. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  19. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  20. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  21. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  22. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  23. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  24. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  25. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  26. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  27. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  28. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  29. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  30. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  31. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  32. Li X, et al. 2022. Cell. 185:1709. PubMed
  33. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  34. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  35. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  36. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  37. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  38. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  39. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  40. Shi H, et al. 2022. Nutrients. 14:. PubMed
  41. Li J, et al. 2022. Elife. 11:. PubMed
  42. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  43. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  44. He Y, et al. 2023. Biomolecules. 13:. PubMed
  45. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  46. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  47. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  48. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  49. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  50. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  51. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  52. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  53. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  54. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  55. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  56. Li Z, et al. 2021. Immunology. 163:105. PubMed
  57. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  58. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  59. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  60. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  61. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  62. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  63. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  64. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  65. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  66. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  67. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  68. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  69. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  70. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  71. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  72. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  73. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  74. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  75. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  76. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  79. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  80. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  81. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  82. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  83. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  84. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  85. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  86. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  87. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  88. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  89. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  90. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  91. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  92. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  93. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  94. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  95. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  96. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  97. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  98. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  99. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  100. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  101. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  102. Wei SC, et al. 2020. Cancer Discov. . PubMed
  103. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  104. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  105. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  106. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  107. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  108. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  109. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  110. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  111. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  112. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  113. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  114. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  115. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  116. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  117. Li N, et al. 2021. eLife. 10:00. PubMed
  118. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  119. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  120. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  121. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  122. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  123. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  124. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  125. Christ A, et al. 2018. Cell. 172:162. PubMed
  126. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  129. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  130. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  131. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  132. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  133. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  134. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  135. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  136. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  137. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  138. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  139. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  140. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  141. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  142. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  143. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  144. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  145. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  146. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  147. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  148. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  149. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  150. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  151. Lang V, et al. 2021. Elife. 10:. PubMed
  152. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  153. Weinstock A, et al. 2021. Elife. :10. PubMed
  154. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  155. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  156. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  157. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  158. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  159. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  160. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  161. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  162. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  163. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  164. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  165. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  166. Thomas K, et al. 2022. JCI Insight. :. PubMed
  167. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  168. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  169. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  170. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  171. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  172. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  173. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  174. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  175. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  176. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  177. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  178. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  179. Calle P, et al. 2021. Cells. 10:. PubMed
  180. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  181. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  182. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  183. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  184. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  185. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  186. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  187. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  188. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  189. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  190. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  191. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  192. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  193. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  194. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  195. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  196. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  197. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  198. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  199. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  200. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  201. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  202. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  203. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  204. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  205. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  206. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  207. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  208. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  209. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  210. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  211. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  212. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  213. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  214. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  215. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  216. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  217. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  218. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  219. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  220. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  221. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  222. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  223. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  224. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  225. Liu SS, et al. 2021. Immunity. :. PubMed
  226. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  227. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  228. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  229. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  230. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  231. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  232. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  233. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  234. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  235. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  236. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  237. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  238. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  239. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  240. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  241. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  242. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  243. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  244. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  245. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  246. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  247. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  248. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  249. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  250. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  251. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  252. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  253. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  254. Zaman R, et al. 2021. Immunity. :. PubMed
  255. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  256. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  257. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  258. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  259. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  260. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  261. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  262. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  263. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  264. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  265. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  266. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  267. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  268. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  269. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  270. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  271. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  272. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  273. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  274. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  275. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  276. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  277. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  278. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  279. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  280. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  281. Li X, et al. 2022. Cell. 185:1709. PubMed
  282. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  283. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  284. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  285. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  286. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  287. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  288. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  289. Shi H, et al. 2022. Nutrients. 14:. PubMed
  290. Li J, et al. 2022. Elife. 11:. PubMed
  291. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  292. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  293. He Y, et al. 2023. Biomolecules. 13:. PubMed
  294. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  295. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  296. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  297. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  298. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  299. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  300. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  301. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  302. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  303. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  304. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  305. Li Z, et al. 2021. Immunology. 163:105. PubMed
  306. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  307. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  308. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  309. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  310. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  311. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  312. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  313. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  314. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  315. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  316. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  317. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  318. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  319. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  320. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  321. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  322. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  323. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  324. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  325. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  326. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  327. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  328. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  329. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  330. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  331. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  332. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  333. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  334. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  335. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  336. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  337. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  338. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  339. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  340. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  341. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  342. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  343. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  344. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  345. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  346. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  347. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  348. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  349. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  350. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  351. Wei SC, et al. 2020. Cancer Discov. . PubMed
  352. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  353. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  354. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  355. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  356. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  357. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  358. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  359. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  360. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  361. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  362. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  363. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  364. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  365. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  366. Li N, et al. 2021. eLife. 10:00. PubMed
  367. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  368. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  369. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  370. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  371. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  372. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  373. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  374. Christ A, et al. 2018. Cell. 172:162. PubMed
  375. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  376. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  377. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  378. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  379. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  380. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  381. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  382. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  383. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  384. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  385. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  386. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  387. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  388. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  389. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  390. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  391. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  392. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  393. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  394. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  395. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  396. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  397. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  398. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  399. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  400. Lang V, et al. 2021. Elife. 10:. PubMed
  401. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  402. Weinstock A, et al. 2021. Elife. :10. PubMed
  403. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  404. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  405. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  406. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  407. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  408. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  409. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  410. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  411. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  412. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  413. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  414. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  415. Thomas K, et al. 2022. JCI Insight. :. PubMed
  416. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  417. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  418. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  419. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  420. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  421. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  422. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  423. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  424. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  425. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  426. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  427. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  428. Calle P, et al. 2021. Cells. 10:. PubMed
  429. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  430. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  431. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  432. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  433. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  434. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  435. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  436. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  437. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  438. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  439. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  440. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  441. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  442. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  443. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  444. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  445. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  446. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  447. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  448. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  449. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  450. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  451. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  452. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  453. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  454. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  455. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  456. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  457. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  458. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  459. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  460. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  461. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  462. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  463. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  464. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  465. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  466. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  467. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  468. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  469. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  470. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  471. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  472. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  473. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  474. Liu SS, et al. 2021. Immunity. :. PubMed
  475. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  476. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  477. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  478. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  479. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  480. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  481. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  482. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  483. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  484. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  485. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  486. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  487. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  488. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  489. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  490. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  491. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  492. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  493. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  494. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  495. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  496. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  497. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  498. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
RRID
AB_893340 (BioLegend Cat. No. 103132)
AB_893344 (BioLegend Cat. No. 103131)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 08.24.2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
103132 100 µg NOK1824
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103131 25 µg NOK718
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  2. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  3. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  4. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  5. Zaman R, et al. 2021. Immunity. :. PubMed
  6. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  7. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  8. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  9. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  10. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  11. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  12. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  13. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  14. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  15. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  16. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  17. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  18. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  19. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  20. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  21. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  22. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  23. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  24. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  25. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  26. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  27. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  28. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  29. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  30. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  31. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  32. Li X, et al. 2022. Cell. 185:1709. PubMed
  33. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  34. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  35. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  36. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  37. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  38. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  39. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  40. Shi H, et al. 2022. Nutrients. 14:. PubMed
  41. Li J, et al. 2022. Elife. 11:. PubMed
  42. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  43. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  44. He Y, et al. 2023. Biomolecules. 13:. PubMed
  45. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  46. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  47. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  48. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  49. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  50. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  51. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  52. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  53. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  54. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  55. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  56. Li Z, et al. 2021. Immunology. 163:105. PubMed
  57. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  58. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  59. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  60. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  61. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  62. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  63. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  64. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  65. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  66. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  67. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  68. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  69. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  70. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  71. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  72. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  73. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  74. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  75. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  76. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  79. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  80. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  81. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  82. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  83. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  84. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  85. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  86. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  87. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  88. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  89. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  90. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  91. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  92. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  93. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  94. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  95. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  96. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  97. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  98. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  99. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  100. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  101. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  102. Wei SC, et al. 2020. Cancer Discov. . PubMed
  103. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  104. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  105. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  106. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  107. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  108. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  109. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  110. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  111. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  112. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  113. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  114. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  115. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  116. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  117. Li N, et al. 2021. eLife. 10:00. PubMed
  118. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  119. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  120. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  121. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  122. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  123. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  124. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  125. Christ A, et al. 2018. Cell. 172:162. PubMed
  126. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  129. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  130. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  131. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  132. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  133. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  134. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  135. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  136. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  137. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  138. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  139. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  140. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  141. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  142. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  143. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  144. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  145. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  146. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  147. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  148. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  149. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  150. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  151. Lang V, et al. 2021. Elife. 10:. PubMed
  152. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  153. Weinstock A, et al. 2021. Elife. :10. PubMed
  154. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  155. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  156. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  157. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  158. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  159. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  160. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  161. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  162. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  163. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  164. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  165. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  166. Thomas K, et al. 2022. JCI Insight. :. PubMed
  167. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  168. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  169. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  170. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  171. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  172. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  173. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  174. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  175. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  176. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  177. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  178. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  179. Calle P, et al. 2021. Cells. 10:. PubMed
  180. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  181. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  182. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  183. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  184. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  185. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  186. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  187. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  188. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  189. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  190. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  191. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  192. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  193. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  194. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  195. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  196. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  197. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  198. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  199. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  200. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  201. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  202. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  203. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  204. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  205. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  206. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  207. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  208. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  209. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  210. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  211. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  212. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  213. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  214. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  215. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  216. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  217. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  218. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  219. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  220. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  221. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  222. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  223. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  224. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  225. Liu SS, et al. 2021. Immunity. :. PubMed
  226. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  227. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  228. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  229. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  230. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  231. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  232. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  233. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  234. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  235. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  236. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  237. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  238. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  239. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  240. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  241. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  242. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  243. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  244. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  245. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  246. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  247. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  248. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  249. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  250. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  251. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  252. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  253. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  254. Zaman R, et al. 2021. Immunity. :. PubMed
  255. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  256. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  257. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  258. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  259. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  260. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  261. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  262. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  263. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  264. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  265. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  266. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  267. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  268. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  269. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  270. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  271. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  272. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  273. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  274. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  275. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  276. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  277. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  278. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  279. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  280. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  281. Li X, et al. 2022. Cell. 185:1709. PubMed
  282. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  283. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  284. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  285. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  286. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  287. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  288. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  289. Shi H, et al. 2022. Nutrients. 14:. PubMed
  290. Li J, et al. 2022. Elife. 11:. PubMed
  291. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  292. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  293. He Y, et al. 2023. Biomolecules. 13:. PubMed
  294. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  295. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  296. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  297. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  298. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  299. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  300. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  301. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  302. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  303. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  304. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  305. Li Z, et al. 2021. Immunology. 163:105. PubMed
  306. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  307. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  308. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  309. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  310. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  311. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  312. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  313. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  314. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  315. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  316. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  317. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  318. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  319. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  320. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  321. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  322. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  323. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  324. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  325. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  326. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  327. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  328. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  329. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  330. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  331. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  332. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  333. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  334. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  335. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  336. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  337. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  338. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  339. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  340. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  341. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  342. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  343. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  344. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  345. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  346. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  347. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  348. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  349. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  350. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  351. Wei SC, et al. 2020. Cancer Discov. . PubMed
  352. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  353. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  354. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  355. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  356. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  357. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  358. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  359. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  360. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  361. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  362. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  363. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  364. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  365. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  366. Li N, et al. 2021. eLife. 10:00. PubMed
  367. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  368. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  369. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  370. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  371. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  372. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  373. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  374. Christ A, et al. 2018. Cell. 172:162. PubMed
  375. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  376. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  377. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  378. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  379. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  380. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  381. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  382. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  383. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  384. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  385. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  386. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  387. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  388. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  389. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  390. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  391. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  392. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  393. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  394. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  395. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  396. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  397. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  398. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  399. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  400. Lang V, et al. 2021. Elife. 10:. PubMed
  401. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  402. Weinstock A, et al. 2021. Elife. :10. PubMed
  403. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  404. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  405. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  406. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  407. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  408. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  409. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  410. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  411. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  412. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  413. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  414. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  415. Thomas K, et al. 2022. JCI Insight. :. PubMed
  416. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  417. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  418. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  419. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  420. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  421. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  422. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  423. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  424. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  425. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  426. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  427. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  428. Calle P, et al. 2021. Cells. 10:. PubMed
  429. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  430. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  431. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  432. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  433. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  434. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  435. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  436. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  437. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  438. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  439. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  440. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  441. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  442. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  443. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  444. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  445. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  446. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  447. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  448. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  449. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  450. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  451. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  452. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  453. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  454. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  455. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  456. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  457. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  458. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  459. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  460. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  461. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  462. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  463. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  464. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  465. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  466. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  467. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  468. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  469. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  470. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  471. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  472. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  473. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  474. Liu SS, et al. 2021. Immunity. :. PubMed
  475. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  476. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  477. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  478. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  479. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  480. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  481. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  482. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  483. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  484. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  485. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  486. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  487. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  488. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  489. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  490. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  491. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  492. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  493. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  494. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  495. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  496. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  497. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  498. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
RRID
AB_893340 (BioLegend Cat. No. 103132)
AB_893344 (BioLegend Cat. No. 103131)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 08.24.2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account